|
Market Closed -
Other stock markets
|
After hours 03:56:47 | |||
| 75.25 USD | +0.64% |
|
75.12 | -0.17% |
| 06-11 | Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction | RE |
| 06-10 | TD Cowen Adjusts Price Target on DexCom to $95 From $75, Maintains Buy Rating | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 29,037 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 12.18% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 28,667 | 27,789 | 26,683 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 9.38% | -3.06% | -3.98% |
| P/E Ratio | 346x | 138x | 95.5x | 54.8x | 31.8x | 30.7x | 25.8x | 21.4x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.2x | 10.9x | 7.84x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.3x | 1.1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 5.56x | 4.98x | 4.45x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.49x | 4.77x | 4.09x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 17.5x | 14.6x | 12x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 23.7x | 19.3x | 15.5x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 28.9x | 22.4x | 17.6x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.47% | 4.47% | 5.68% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.448 | 2.921 | 3.51 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,225 | 5,830 | 6,525 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,637 | 1,909 | 2,218 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,212 | 1,437 | 1,721 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 962.6 | 1,158 | 1,378 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -369.5 | -1,248 | -2,354 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 75.25 | 75.25 | 75.25 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 385,873 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E Ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.74x | 5.49x | 17.51x | -.--% | 29.04B | |
| 22.55x | 3.34x | 12.55x | 2.84% | 156B | |
| 20.19x | 3.49x | 12.53x | 3.56% | 103B | |
| 14.83x | 0.18x | 11.12x | 0.84% | 54.77B | |
| 34.95x | 8.63x | 23.22x | 1.1% | 53.52B | |
| 36.72x | 2.94x | 10.1x | 2.62% | 40.6B | |
| 35.54x | 1.31x | 11.57x | 0.22% | 31.4B | |
| 39.23x | 6.78x | 24.48x | 0.27% | 23.34B | |
| 24.42x | 3.11x | 12.7x | 1.32% | 20.81B | |
| 22.99x | 3.32x | 11.92x | 1.27% | 20.23B | |
| Average | 28.22x | 3.86x | 14.77x | 1.4% | 53.3B | |
| Weighted average by Cap. | 25.66x | 3.68x | 14.00x | 2.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
